Cefdinir and Fluocinonide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefdinir (cefdinir) and Fluocinonide (fluocinonide). Common drug interactions include metabolic acidosis among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Cefdinir and Fluocinonide. It is created by eHealthMe based on reports of 67 people who take the same drugs from the FDA, and is updated regularly.

What is Cefdinir?

Cefdinir has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 9,210 Cefdinir users. Check the latest studies of Cefdinir.

What is Fluocinonide?

Fluocinonide has active ingredients of fluocinonide. It is often used in eczema. eHealthMe is studying from 6,385 Fluocinonide users. Check the latest studies of Fluocinonide.



On Jul, 10, 2026

67 people who take Cefdinir and Fluocinonide together, and have interactions are studied.

Cefdinir and Fluocinonide drug interactions.

What are the common drug interactions of Cefdinir and Fluocinonide, by gender? *:

female:

  1. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  2. Muscle spasms (muscle contraction)
  3. Myalgia (muscle pain)
  4. Nausea (feeling of having an urge to vomit)
  5. Oral herpes (viral infection of mouth)
  6. Pruritus (severe itching of the skin)
  7. Pulmonary mass
  8. Retinal pigmentation (pigmentation of retina)
  9. Chronic kidney disease
  10. Pain

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Blood glucose increased
  4. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  5. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  6. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  7. Cough
  8. Disease progression
  9. Dizziness
  10. Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Cefdinir and Fluocinonide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Skin candida (fungal infection of skin)
  2. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  3. Fistula (an abnormal connection or passageway between two)
  4. Hepatotoxicity (chemical-driven liver damage)
  5. Post procedural fistula

20-29:

  1. Injection site pain
  2. Urticaria (rash of round, red welts on the skin that itch intensely)

30-39:

  1. Blindness transient (sudden loss of vision)
  2. Bone disorder
  3. Cardiac murmur (an heart sound in valve abnormality)
  4. Disability
  5. Hypersensitivity
  6. Immobile (not moving)
  7. Muscle injury
  8. Muscular weakness (muscle weakness)
  9. Pemphigoid (tense blisters on the skin)
  10. Rash

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Bone density decreased
  5. Emotional distress
  6. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  7. Osteoporosis (bones weak and more likely to break)
  8. Pain
  9. Bone loss
  10. Osteonecrosis (death of bone)

50-59:

  1. Chronic kidney disease
  2. Drug ineffective
  3. Infection
  4. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  5. Oral herpes (viral infection of mouth)
  6. Pruritus (severe itching of the skin)
  7. Rash
  8. Urticaria (rash of round, red welts on the skin that itch intensely)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Parkinson's disease
  4. Peripheral swelling
  5. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  6. Abdominal discomfort
  7. Abdominal distension
  8. Alopecia (absence of hair from areas of the body)
  9. Arteriosclerosis (thickening and hardening of arteries)
  10. Blood glucose increased

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 22 people, 32.84%
  2. Pain: 13 people, 19.40%
  3. Hypersensitivity: 11 people, 16.42%
  4. Stress And Anxiety: 11 people, 16.42%
  5. Depression: 11 people, 16.42%
  6. Nausea (feeling of having an urge to vomit): 11 people, 16.42%
  7. Irritable Bowel Syndrome: 10 people, 14.93%
  8. High Blood Cholesterol: 9 people, 13.43%
  9. Fever: 8 people, 11.94%
  10. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 7 people, 10.45%

* Approximation only. Some reports may have incomplete information.

Do you take Cefdinir and Fluocinonide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cefdinir and Fluocinonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefdinir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fluocinonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefdinir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fluocinonide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefdinir and fluocinonide (the active ingredients of Cefdinir and Fluocinonide, respectively), and Cefdinir and Fluocinonide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: